Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs Notified -
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults Notified -
TestMu AI Introduces Run-by-Run Comparison in App Profiling Insights, Enabling Teams to Trace Mobile Performance Regressions to Device, OS Version or Build Notified -
New research reveals the “cooling dividend” for workers and entrepreneurs facing extreme heat Notified -
AI Kill Switch: The Race to Control Rogue Frontier AI & AGI Models (Veterans First for America) Notified -
Schneider Electric launches new Motivair coolant distribution unit integrating liquid and air cooling for more flexible data center deployments Notified -
Boehringer Ingelheim and AWARE launch new Stop Rabies project in Zimbabwe to help protect dogs and communities Notified -
NIO and HERE Technologies expand European collaboration to support fresher maps and Navigation on Autopilot driving experiences Notified -